SMi’s 22nd Annual Superbugs and Superdrugs Conference

Start Date : March 30, 2020
End Date : March 31, 2020
Time : 8:30 am to4:40 pm

Phone : 02078276000
Email : ssapal@smi-online.co.uk

Location :
Holiday Inn London - Kensington Forum, 97 Cromwell Road, London, England, SW7 4DN, United Kingdom

Website

Description

Sponsored by Scynexis

CO-CHAIRS FOR 2020:
Cara Cassino, Chief Medical Officer, Contrafect
Michael Dawson, Director, Mike Dawson Antimicrobial Research Consultancy

As one of the most impactful pharmaceuticals for maintaining public health, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal, including colistin, carbapenems, 3rd and 4th generation cephalosporins, useless.
This year’s event aims to showcase a suite of sessions focused on novel drugs and approaches, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR.
It is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020, along with leaders from the pharmaceutical industry, academia, regulatory and funding bodies, and public-private partnerships to discuss the way forward.

Prices:

Conference Only: GBP 1499.00,
Conference and 1 workshop only: GBP 2098.00,
Conference and 2 workshops: GBP 2697.00,
Conference Presentations – paper copy: GBP 499.00,
Access to the conference documentation on the Document Portal: GBP 499.00,
Promotional Literature Distribution: GBP 999.00

URLs:

Brochure: https://go.evvnt.com/538855-3?pid=3506

Sponsor: https://go.evvnt.com/538855-4?pid=3506

Speakers: CO-CHAIR – Cara Cassino, Chief Medical Offi cer, Contrafect, CO-CHAIR – Michael Dawson, Director, Mike Dawson Antimicrobial Research Consultancy, Yuri Gleba, Professor, Founder, Nomad Bioscience, Samareh Lajaunias, Director, Combioxin SA, Cara Cassino, Chief Medical Offi cer, Contrafec, Mark Albrecht, Branch Chief, Antibacterials Program, BARDA/HHS, Stephen Barat, VP, Research and Early Development, Scynexis, Pedro Madureira, Co-Founder, CSO, Immunethep, Pedro Madureira, Co-Founder, CSO, Immunethep, Toni Perez, Chief Medical Offi cer, Senior Subject Matter Expert, Combioxin, Colm Leonard, Consultant Clinical Adviser/Consultant Thoracic Physician/Honorary Professor of Medicine, NICE and Machester University NHS Foundation Trust, Paul Finn, CEO, Oxford Drug Design, Martin Everett, CSO, Antabio, Francois Moreau, Scientifi c Director, Mutabilis, Daniel Walker, Professor of Bacteriology, University of Glasgow, Lorenzo Corsini, Co-Founder/CEO/R&D, Phagomed, David Roper, Professor of Biochemistry and Structural Biology, University of Warwick, Emma Leire, Microbiology Lead, Centauri Therapeutics, Peter Warn, Senior Vice President Anti-infective Discovery, Evotec (UK) Ltd, Antonio Felici, VP, Anti-Infectives, Evotec, Stephen Barat, VP, Preclinical Research and Early Development, Scynexis

Organized by

Organized by LoveEvvnt1

SMi Group

Tel: 02078276000
Email: ssapal@smi-online.co.uk


Event Categories: Health & Nutrition and Internal Medicine.




Your Review

You must be logged in to post a comment.